Going digital in its 2nd year, the Blood-Brain Barrier (BBB) Summit is the industry’s definitive BBB conference focused on sharing the latest scientific advances, data and key lessons learned for transporting more drugs across the BBB.

With a heavy focus on biologics, for neurodegenerative diseases, this summit will discuss topics such as quantitative methodologies for measuring amount and distribution of antibodies in the brain, using PKPD systems to improve translation and predict clinical outcomes and importantly, progress in the validation of approaches and technologies which enhance BBB transition.

Moreover, this meeting also aims to deepen your understanding of intracellular trafficking and receptor binding, pharmacokinetics and protein engineering to drive the clinical applicability of receptor mediated transcytosis. The 2nd BBB Summit delves into identifying gaps in the physiology of the BBB and questions the extent of the relationship between the BBB and different disease states in various neurodegenerative diseases as well as uncovering what makes neural exosomes efficient BBB drug delivery tools.

Join fellow BBB specialists virtually to scrutinize progress of existing approaches to deliver more of your biologic therapeutic across the BBB to develop a clinically defining neurodegenerative treatment.

Take a look at the full event guide here.